Buy Nureca, Anupam Rasayan, add Latent View, Supriya Life on dips: IIFL’s Sanjiv Bhasin

2021 has been a year of heavy primary market activity with a lot of companies going public from Nykaa to Paytm and brought with it heightened conversation around the sky-high valuations. In an interview to CNBC-TV18, Sanjiv Bhasin, director of IIFL Securities spoke at length about primary market activity.

“We cover Nureca. It’s a digital company that gives everything from curative to preventive, pre-diagnostics to diagnostics and valuations are extremely reasonable. I think that could be a multi-bagger,” said Bhasin.

He is also bullish on Anupam Rasayan and expects the stock price to double from hereon.